177 related articles for article (PubMed ID: 24032676)
1. Therapeutic potential of amniotic fluid-derived cells for treating the injured nervous system.
Rennie K; Haukenfrers J; Ribecco-Lutkiewicz M; Ly D; Jezierski A; Smith B; Zurakowski B; Martina M; Gruslin A; Bani-Yaghoub M
Biochem Cell Biol; 2013 Oct; 91(5):271-86. PubMed ID: 24032676
[TBL] [Abstract][Full Text] [Related]
2. Neurogenic potential of mesenchymal-like stem cells from human amniotic fluid: the influence of extracellular growth factors.
Orciani M; Morabito C; Emanuelli M; Guarnieri S; Sartini D; Giannubilo SR; Di Primio R; Tranquilli AL; Mariggiò MA
J Biol Regul Homeost Agents; 2011; 25(1):115-30. PubMed ID: 21382281
[TBL] [Abstract][Full Text] [Related]
3. Human amniotic fluid: a source of stem cells for possible therapeutic use.
Dziadosz M; Basch RS; Young BK
Am J Obstet Gynecol; 2016 Mar; 214(3):321-7. PubMed ID: 26767797
[TBL] [Abstract][Full Text] [Related]
4. Amniotic fluid cells and human stem cell research: a new connection.
Prusa AR; Hengstschlager M
Med Sci Monit; 2002 Nov; 8(11):RA253-7. PubMed ID: 12444390
[TBL] [Abstract][Full Text] [Related]
5. Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels.
Mareschi K; Rustichelli D; Comunanza V; De Fazio R; Cravero C; Morterra G; Martinoglio B; Medico E; Carbone E; Benedetto C; Fagioli F
Cytotherapy; 2009; 11(5):534-47. PubMed ID: 19548144
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells.
McLaughlin D; Tsirimonaki E; Vallianatos G; Sakellaridis N; Chatzistamatiou T; Stavropoulos-Gioka C; Tsezou A; Messinis I; Mangoura D
J Neurosci Res; 2006 May; 83(7):1190-200. PubMed ID: 16555279
[TBL] [Abstract][Full Text] [Related]
7. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells.
Tsai MS; Hwang SM; Tsai YL; Cheng FC; Lee JL; Chang YJ
Biol Reprod; 2006 Mar; 74(3):545-51. PubMed ID: 16306422
[TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid harbours multipotent stem cells.
Reprod Biomed Online; 2007 Mar; 14(3):395. PubMed ID: 17359597
[No Abstract] [Full Text] [Related]
9. An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineering.
Gholizadeh-Ghaleh Aziz S; Fathi E; Rahmati-Yamchi M; Akbarzadeh A; Fardyazar Z; Pashaiasl M
Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):765-774. PubMed ID: 27684534
[TBL] [Abstract][Full Text] [Related]
10. Stem cells from amniotic fluid--Potential for regenerative medicine.
Loukogeorgakis SP; De Coppi P
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():45-57. PubMed ID: 26542929
[TBL] [Abstract][Full Text] [Related]
11. Amniotic fluid stem cells increase embryo survival following injury.
Prasongchean W; Bagni M; Calzarossa C; De Coppi P; Ferretti P
Stem Cells Dev; 2012 Mar; 21(5):675-88. PubMed ID: 21905920
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice.
Rehni AK; Singh N; Jaggi AS; Singh M
Behav Brain Res; 2007 Oct; 183(1):95-100. PubMed ID: 17619060
[TBL] [Abstract][Full Text] [Related]
13. Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration.
Da Sacco S; De Filippo RE; Perin L
Curr Opin Organ Transplant; 2011 Feb; 16(1):101-5. PubMed ID: 21157345
[TBL] [Abstract][Full Text] [Related]
14. Amniotic fluid-derived stem cells in regenerative medicine research.
Joo S; Ko IK; Atala A; Yoo JJ; Lee SJ
Arch Pharm Res; 2012 Feb; 35(2):271-80. PubMed ID: 22370781
[TBL] [Abstract][Full Text] [Related]
15. Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.
Kang NH; Hwang KA; Kim SU; Kim YB; Hyun SH; Jeung EB; Choi KC
Cancer Gene Ther; 2012 Aug; 19(8):517-22. PubMed ID: 22653384
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy.
Antonucci I; Stuppia L; Kaneko Y; Yu S; Tajiri N; Bae EC; Chheda SH; Weinbren NL; Borlongan CV
Cell Transplant; 2011; 20(6):789-95. PubMed ID: 21054947
[TBL] [Abstract][Full Text] [Related]
17. Transplantation for stroke.
Roitberg B
Neurol Res; 2004 Apr; 26(3):256-64. PubMed ID: 15142317
[TBL] [Abstract][Full Text] [Related]
18. A humanized system to expand in vitro amniotic fluid-derived stem cells intended for clinical application.
Martinelli D; Pereira RC; Mogni M; Benelli R; Mastrogiacomo M; Coviello D; Cancedda R; Gentili C
Cytotherapy; 2016 Mar; 18(3):438-51. PubMed ID: 26857233
[TBL] [Abstract][Full Text] [Related]
19. [Amniotic fluid: a novel source for tissue engineering].
Li XD; Geng HQ; Pan J; Xie H; Chen F
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):464-7. PubMed ID: 15854552
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
